Background

Mucopolysaccharidosis (MPS) are inborn errors of metabolism (IEM) recognized by deficient enzymes enrolled in glycosaminoglycans catabolism. The resulting accumulation of glycosaminoglycans leads to clinical progressive and generalized manifestations inherited by autosomal recessive, except in MPS type II inherited as an X-linked trait [1]. The most frequent clinical manifestations comprehend short stature, coarse facial features, cornea opacification, heart disease, hepatosplenomegaly, multiple dysostoses, joint stiffness, claw hands, and arthralgia. Repetitive respiratory infections, hypertrophy of the tongue, palatine and adenoid tonsils, alterations in the stomatognathic system, hirsutism, thickening of the skin and mucous membranes, hearing loss and neurological dysfunction [2].

The treatment of IEM has been developed throughout the last years. Even though the new therapeutics achieved does not represent cure for many conditions, they are a significant hallmark in improving quality of life and lifespan increase of patients. The treatment of MPS is based on ameliorating symptomatic manifestations organized by a multidisciplinary team, bone marrow transplantation, and enzymatic replacement therapy [3].

Although MPS are not IEM specifically treated with diet, patients take advantage of nutritional assistance. In fact, some aspects of this disease such as osteoarticular involvement and small stature demand caution in follow-up when related to nutritional condition [4].

Studies have pointed out to alterations in the stomatognathic system, which lead to dysfunction in mastication and deglutition [2] and promote gastrointestinal alterations, especially diarrhea and constipation [5,6,7]. Moreover, neurological symptoms may influence food intake by appetite alterations as well as by a dependence on a caregiver for nutritional handling [8].

Evidence has shown alterations in energetic need since there is an increase in caloric intake and body mass maintenance and decreased accumulation in lipids in adipocytes [9, 10].

Considering the severity of MPS and the relevance of establishing dietetic strategies to these patients, the present study was tailored to evaluate the food intake in patients with MPS types I, II, and VI.

Methods

A transversal descriptive study was conducted including patients with MPS under enzyme replacement therapy (ERT) from the Centro de Referência em Erros Inatos do Metabolismo da Universidade Federal de São Paulo (CREIM/UNIFESP). Patients who displayed severe neurological symptoms, hyperactive behavior, or irritability were not included in the study because their evaluation could be hampered.

During the inclusion period, 33 patients were receiving ERT in CREIM. Ten patients were excluded from the study for not fulfilling the criteria. Three patients did not accept participation or their participation was not allowed, and 20 patients voluntarily accepted participation. These patients received specific instructions regarding the procedures. All of the patients or their legal responsible read and signed the informed consent form.

Energetic necessity was obtained by prediction equations that considered gender, body mass (kg), height (m), and levels of physical activity (sedentary, low active, active, and very active). Food intake found between two standard deviations of estimated necessity was considered adequate.

During appointment, patients were interrogated about food intake from 24 h prior to consultation. This procedure was made twice with intervals that varied from 6 to 12 months. Data were analyzed (total energetic value (TEV), proteins, carbohydrates, lipids, and percent of macronutrients and micronutrients: vitamins B1, B2, B3, and C and calcium, iron, and phosphorus) using AVANUTRI Software (Version Revolution 4.0; Avanutri & Nutrition Services and Informatics Limited ME).

Carbohydrate, lipid, and protein intake evaluation was made using the percent of macronutrients in relation to TEV. The obtained value was ranked in accordance to the acceptable distribution interval of macronutrients, namely acceptable macronutrient distribution range (AMDR) [11].

Individual’s micronutrient intake (vitamins and minerals) was assessed by the “apparent dietary adequacy” method which was proposed by Institute of Medicine’s Food and Nutrition Board [12]. In this method, the probability of adequacy (or inadequacy risk) is assessed by comparing the usual dietary intake to the Dietary Reference Intakes (DRIs): EAR (estimated average requirement), AI (adequate intake), and UL (upper level) [12, 13].

The result is a z-score value obtained using the observation of average nutrient intake. The individual intake evaluation was based on the probability of adequacy in accordance to the obtained z-score. When the obtained z-score was equal or higher than 50%, the probability of adequacy was determined. Oppositely, if the obtained z-score was smaller than 50%, it was considered inadequate.

Children and adolescents were grouped together for the evaluation of studied variables. The probability of adequacy for each nutrient was compared to the normal distribution (Kolgomorov-Smirnov). A posterior t test was applied. A level of significance of 10% was adopted.

The study was approved by the local Institutional Review Boards/the Ethics Committee of the Universidade Federal de São Paulo/Hospital São Paulo under the protocol #0763/11. Consent to publish has been obtained from all involved participants and parent or guardian for children.

Results

The food intake of 17 patients was analyzed: 8 patients with MPS I (4 females), 5 male patients with MPS II, and 4 patients with MPS VI (3 females and 1 male). The minimum age of the sample was 6 years and the maximum 30. The food intake of three patients was not analyzed because the companion was not the caregiver.

Table 1 details the energy and macronutrients intake (kcal) and the evaluation of average intake of children, adolescents, and adults according to standard deviation. None of the children or adolescents displayed adequate intake (± 2 standard deviations). Of note, 71.4% of children presented food intake higher than 2 standard deviations. In the adult group, the energy consumption was adequate in 60% of the patients and none of the patients presented energy consumption above the recommended levels. Regarding macronutrient distribution, no alteration was detected (Fig. 1).

Table 1 Energy (kcal) intake (average, minimum, and maximum), evaluation of adequate intake in standard deviation and macronutrients (g) in children, adolescents, and adults with mucopolysaccharidosis (MPS)
Fig. 1
figure 1

Distribution of the percent of energy consumption from macronutrients in children, adolescents, and adults with mucopolysaccharidosis (MPS). São Paulo, 2012-2013

Analyzing the four studied vitamins, more than half of the children sample presented probability of adequacy higher than 50% (71.4 to 85%). Conversely, more than half of the adults showed probability of adequacy for vitamin B2 intake smaller than 50%. Concerning mineral intake, calcium intake should be highlighted. Indeed, the intake of this mineral presented probability of adequacy smaller than 50% in 13 out of 17 evaluated patients (76.5%). On the other hand, the probability of inadequacy of iron intake was approximately 50% among patients irrespective of age (Table 2).

Table 2 Sample distribution according to the evaluation of probability of adequacy of vitamins and minerals intake

When the food intake patterns of children and adolescents were compared to those presented by adults, children and adolescents displayed a better pattern of vitamin intake (B1, B2, B3, and C) and iron. Indeed, the frequency of the probability of adequacy was ≥ 50%, especially for vitamin B1 (p < 0.05) and C (p < 0.77). The calcium and phosphorus intake was better in adults compared to that in children and adolescents.

The average intake of macronutrients, vitamins, and minerals as well as the minimum and maximum intake for each group are detailed in Table 3.

Table 3 Average intake of vitamins and minerals (mean, minimum, maximum, and DRI) in 17 patients at different ages (children, adolescents, and adults) with mucopolysaccharidosis (MPS)

Discussion

Nutritional recommendation for patients with MPS is similar to that for healthy patients, with no especial pattern of recommendation. The dietetic treatment does not only aim to correct diarrhea and constipation but also help in the consistency of the dysphagia treatment.

In the present study, approximately half of the evaluated patients presented probable adequacy in vitamin (B1, B2, and B3) levels since they are largely spread in the food. These vitamins may participate in energetic metabolism, in redox reactions. In this regard, niacin plays a critical role in nucleic acids, fatty acids and cholesterol synthesis, DNA repair, and steroid hormones production [14].

The intake of vitamins and iron was higher in children and adolescents than that in adults, especially that of vitamins B1 and C. The increased levels of nutrient intake in children may be related to the average daily calorie quantity. Conversely, the intake of calcium and phosphorus, which are found in milk and milk derivatives, was higher in adults.

The majority of the patients showed probability of adequacy ≥ 50% for vitamin C. The inflammatory nature of the lysosomal diseases should be highlighted [15] especially MPS [16]. Thus, this pattern may lead to increased necessity of nutrients with antioxidant action such as ascorbic acid [17] because the disease-induced oxidative stress may deplete this nutrient [18].

In a previous study in the same population, the fruit, vegetable, and green intake was smaller than that recommended by the guidelines on nutrition for Brazilian population. The majority of enrolled population had inadequate quantities of grains, tubercle, fruit, and vegetables (submitted data).

The decrease in fruit, vegetable, and legume intake is an ordinary phenomenon observed in Brazilian population due to an increased consumption of ultra-processed in substitution to minimally processed food [19].

Calcium and phosphorus intake was higher in adults since the majority of children and adolescents presented probability of adequacy smaller than 50%. In Sao Paulo state, it was reported that calcium intake inadequacy was higher than 70% among adolescents and adults [20].

Regarding low adequacy of calcium and phosphorus intake, children with MPS demand more attention in regulating the intake of these nutrients since they participate in structural formation (teeth, bones, and connective tissues) and diverse metabolic ways. Additionally, the intake of these nutrients is also critical for growth, development, and good physiological function [21].

In MPS, the establishment of an ideal calcium metabolism constitutes an obstacle due to the altered calcium homeostatic and cellular metabolism found in IEM [22]. In line with this assumption, studies have shown that these patients may present low bone mineral density when chronological age and gender are considered. However, these data are questionable because bone diseases, as osteoporosis and osteomalacia for instance, are not accurately diagnosed in MPS. In fact, abnormal bone geometry may hamper precise diagnostics [23]. Apart from that, the equipment and equations involved in diagnostics are set for normal pattern of morphology found in the general population, not in MPS.

Over 50% of studied population displayed probability of adequacy ≥ 50% in iron intake. This nutrient has deficiency in higher magnitude worldwide and is verified in all segments being associated to insufficient iron quantity in the diet able to provide individual nutritional necessity [24]. The deficiency of this nutrient may affect both growth and development in children and adolescents and also influence the work ability and the immune response [25, 26]. For this reason, Brazil adopted a compulsory iron fortification of wheat or corn flour, which is considered the best cost-benefit measure to reduce the prevalence of iron deficiency [25].

In MPS, an important factor of iron intake is inflammation [15], because this process leads to a reduction in hepcidin, a hormone responsible for iron absorption [27].

Herein, macronutrients intake was found in accordance with that recommended by AMDR [11] as well as the intake proportion found in the Brazilian survey of familiar budget [19, 28]. However, the energy consumption of none of the children and adolescents was adequate energetic intake. The majority of children had more caloric intake than that estimated for age, gender, and stature. On the other hand, caloric intake was adequate in adults. Together, these results may suggest that the increased physiology energetic demand in childhood and adolescence allied to the metabolic alterations found in MPS may establish or decrease during adulthood.

Studies that evaluated the food intake or energetic demand in MPS are scarce. A study had analyzed seven patients with MPS II at age of 5 to 14 years. The authors have verified that the average energetic intake was smaller than the energetic demand. However, the energetic value may have been super estimated because activity is a factor with large variability in this population [29].

Studies using animal models of MPS types I and VII have reported that there is an increase in food intake that could lead to a decreased use of energy due to lysosomal accumulation [9].

In the same context, an increased autophagy caused by an energetic misbalance was found in animals. The authors have attributed this misbalance to lysosomal dysfunction, which may had kidnaped metabolites, stimulating protein degradation. This greater protein degradation occurred to maintain the intermediary metabolism in response to carbohydrates and lipids, corrected after higher intake of carbohydrates and fat [10]. ERT also contributed by increasing the glycosaminoglycans catabolism and releasing monosaccharaides into the cytosol. Such mechanism leads to a reduction in the energy requirement from the de novo synthesis, thus the demand for raw material was lower.

The current phenomenon of nutritional transition amplifies the risk of developing non-transferable chronic diseases and their morbidity or associated nutritional deficiencies in the general population. Patients with MPS are also part of this context even though their nutritional pattern, such as necessity of energy or micronutrients or even macronutrients adequate intake, still remains neglected, worsening this clinical condition.

Conclusion

The nutritional assessment in the present study showed that despite the overall macronutrients intake in levels recommended by AMDR, MPS patients presented an inadequate energy and micronutrient consumption. The present data suggests that patients with MPS could benefit from monitoring and nutritional counseling, given the inadequacy of the nutrient intake and its direct and/or indirect implications for the course of the disease in different stages of life. Such strategies could promote quality of life and minimize the effects of possible nutritional deficiencies (both macro and micronutrients) in this population.